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1. Introduction 
1.1 Endothelial inflammatory signaling and monocyte recruitment  
Recruitment of circulating monocytes to activated areas of the endothelium and their 
migration to the subintimal inflammatory foci represents one of the earliest events in 
atherogenesis (Linton and Fazio 2003; Hansson 2005). Importantly, monocyte recruitment 
can be recognized throughout all lesional stages including advanced lesions, where plaque 
infiltration and neovascularization occur. Indeed, available experimental evidence supports 
the notion that in advanced stages monocyte infiltration contributes to plaque instability 
and rupture (Virmani, Burke et al. 2006). Monocyte recruitment to the subendothelial milieu 
implies a sequence of events that begin with monocyte rolling along and tethering to the 
endothelial surface, firm adhesion and activation, and ultimately migration to the 
subintima. At the molecular level, the entire sequence entails interaction of integrins on the 
monocyte surface with cell adhesion molecules (CAMs) expressed on the endothelial cell. 
Monocyte rolling and tethering is mainly mediated by CAMs from the selectin group (v.g., 
E-selectin) while firm adhesion and migration are mostly mediated by CAMs from the 
immunoglobulin (Ig) superfamily, such as intercellular cell adhesion molecule-1 (ICAM-1) 
and vascular cell adhesion molecule-1 (VCAM-1). Compelling evidence accumulated over 
the last decade has clearly established that VCAM-1 (CD106) has a prominent role in 
mediating attachment and migration of monocytes (the Cluster of Differentiation 
nomenclature (Zola, Swart et al. 2005) is given for reference, but “VCAM-1” will be used 
throughout the text).  
1.1.1 VCAM-1 expression and atherosclerosis  
Although other adhesion molecules, such as ICAM-1 (CD54) or E-selectin, also contribute 
to adhesion of monocytes to endothelial cells, VCAM-1 is unique in that its expression 
level and pattern are highly sensitive to the action of several pro-inflammatory/pro-
atherogenic stimuli. While other CAMs are constitutively expressed in non-activated 
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endothelium, VCAM-1 is virtually absent, but its markedly upregulated when 
endothelium is exposed to atherorelevant stimuli (Galkina and Ley 2007). For example, in 
hypercholesterolemic animals both ICAM-1 and VCAM-1 are induced in early lesions. 
However, VCAM-1 expression is largely restricted to lesions, or to sites prone to lesion 
formation, and can also be detected even before the onset of visible fatty streaks, while 
ICAM-1 also extends into uninvolved aorta and lesion-protected regions (Iiyama, Hajra et 
al. 1999). This dissimilar pattern immediately suggested different functions for ICAM-1 
and VCAM-1, at least in lesion initiation. A more direct comparison of VCAM-1 and 
ICAM-1 in atherosclerosis was possible through generation of mice homozygous for a 
VCAM-1 molecule lacking the Ig-like extracellular domain 4 (Vcam1D4D/D4D) which 
partially circumvents the embryonic lethality of Vcam-1-/- mice. Using such mouse model 
it was possible to show that whereas both ICAM-1 and VCAM-1 are upregulated in 
lesions, VCAM-1 has a dominant role in early lesion formation (Cybulsky, Iiyama et al. 
2001; Dansky, Barlow et al. 2001). Atherorelevant stimuli such as tumor necrosis factor-ǂ 
(TNFǂ), locally released nucleotides, vascular endothelial growth factor (VEGF) or 
oxidized low density lipoprotein (oxLDL), are potent inducers of VCAM-1 expression 
(Galkina and Ley 2007). Depending on the stimulus and/or the regional location of the 
endothelial cell along the vascular bed, VCAM-1 expression is regulated through Nuclear 
Factor κappaB (NFκB), Nuclear Factor of Activated T cells (NFAT) or both (Armesilla, 
Lorenzo et al. 1999; Kim, Moon et al. 2001; Yao and Duh 2004).  
1.1.2 VCAM-1 structure and function  
Human VCAM-1 is a single transmembrane protein with seven Ig-like extracellular 
domains (1-7) but can also be expressed as a form with only domains 1-3 and 5-7 
(Chuluyan, Osborn et al. 1995). The extracellular domains 1 and 4 mediate specific 
binding to the integrin ǂ4ǃ1 (Very Late Antigen 4, VLA-4) on the monocyte facilitating 
firm adhesion to the endothelium. The cytoplasmic domain is only 19 amino acids long, 
and has a PDZ-binding motif, but specific interactions or functional relevance remain 
unknown. Interaction of VCAM-1 with ǂ4ǃ1 conveys a conformational message through 
the transmembrane domain towards the cytosolic region, triggering intracellular signaling 
events. Importantly, VCAM-1-dependent signaling is a prerequisite for successful 
migration of bound monocytes (Matheny, Deem et al. 2000; Deem, Abdala-Valencia et al. 
2007). Some salient features within this signaling are the recruitment and activation of the 
Rho-family GTPase Rac-1, Rac-1 dependent stimulation of NADPH oxidase and 
production of hydrogen peroxide (H2O2) (van Wetering, van den Berk et al. 2003). VCAM-
1-dependent release of H2O2 to the extracellular milieu is thought to contribute to 
activation of matrix metalloproteases and the increased endothelial permeability observed 
during atherogenesis. This may be particularly important in advanced lesions by creating 
additional endothelial damage and plaque instability (Virmani, Burke et al. 2006). 
Calcium (Ca2+) release and influx subsequent to VCAM-1-ǂ4ǃ1 interaction or antibody-
induced VCAM-1 crosslinking have also been related to the signaling required for 
monocyte migration (Isabelle Ricard 1997; Cook-Mills 2002; Cook-Mills, Johnson et al. 
2004). However, neither the nature of the channels involved nor the underlying 
mechanism/s are yet known. In coronary artery endothelial cells of human origin 
(HCAECs) activation of VCAM-1 by antibody-induced crosslinking results in 
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approximately three-fold increase in the rate of cation influx compared to non-treated 
cells (Smedlund and Vazquez, unpublished observations). Such increase in cation influx 
occurs over the existing constitutive influx, and thus is possible that both constitutive and 
regulated activity of cation channels play a role. Because TRPC3 accounts for most of the 
constitutive cation entry in HCAECs and also significantly contributes to regulated influx 
(Vazquez and Putney 2006; Smedlund and Vazquez 2008) it is likely that TRPC3 
represents a component of the signaling underlying VCAM-1-dependent monocyte 
transmigration. 
1.2 Role of macrophage survival and apoptosis in lesion development  
As mentioned above, monocyte recruitment to the subintima is a fundamental event in 
atherogenesis (Linton and Fazio 2003). Transmigration of the monocyte to the 
subendothelial milieu is followed by its differentiation into macrophage, which is now 
recognized as a key cell component in determining lesion progression and fate. Lesional 
macrophages engulf modified lipoproteins, mostly oxLDL, becoming lipid-laden 
macrophages; this results in a lipid overload of the macrophage which imposes a significant 
stress to the endoplasmic reticulum (ER), mostly due to accumulation of free cholesterol. 
Consequently, an irreversible ER-stress response is triggered leading to macrophage 
apoptosis. Indeed, the majority of apoptotic lesional cells are macrophages (Linton and 
Fazio 2003; Tabas 2010). Clearance of apoptotic cells is conducted by resident phagocytes, 
which phagocytose the apoptotic macrophage and exit the lesion site through lymphatic 
circulation or by migrating back to the blood stream. This clearing process, known as 
efferocytosis, is crucial in preventing the apoptotic cells from dying in situ which would 
otherwise lead to post-apoptotic necrosis and the subsequent exacerbation of the 
inflammatory response. Notably, the balance between production of apoptotic macrophages 
and their clearance by efferocytosis constitutes a defining factor in lesion formation, 
remodeling and progression ((Tabas 2010) and references therein). For instance, macrophage 
apoptosis in early lesions is beneficial in that reduces lesion cellularity and size and plaque 
progression (Arai, Shelton et al. 2005; Liu, Thewke et al. 2005; Babaev, Chew et al. 2008; 
Wang, Liu et al. 2008) while increased apoptosis in advanced plaques enlarges the necrotic 
core and promotes plaque instability (Linton, Babaev et al. 1999; Seimon, Wang et al. 2009; 
Yancey, Blakemore et al. 2010). Thus, altered expression and/or deregulation of signaling 
proteins directly or indirectly involved in macrophage survival/apoptosis can have a 
significant impact on lesion progression. 
2. TRPC channels 
2.1 Structure, function and role in cardiovascular disease  
Calcium influx has long been recognized as an essential component of physiological and 
pathophysiological events. Changes in intracellular Ca2+ concentration that follow Ca2+ 
influx through plasma membrane Ca2+ channels not only modulate a myriad of Ca2+-
dependent signaling pathways but also affect the driving force for other ions by modifying 
the membrane potential. Ca2+ influx is of particular importance in vascular function and 
cardiovascular disease, where the effects of Ca2+ influx can be seen throughout the entire 
cardiovascular system, in smooth muscle and endothelial cells, cardiomyocytes, 
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lymphocytes, monocytes, macrophages, among other cell types. Of the many Ca2+ channels 
identified in the last half century, Transient Receptor Potential Canonical (TRPC) channels 
are recognized as major contributors to Ca2+ influx and play a role in various physiological 
and pathological states. The TRPC family belongs to the TRP superfamily of ion channel 
forming proteins, and are the most closely related to the founding member Drosophila TRP 
protein (Vazquez, Wedel et al. 2004). TRPC proteins can be grouped into four subgroups, 
TRPC1, TRPC2 (a pseudogene in humans), TRPC3/6/7 and TRPC4/5 (Trebak, Vazquez et 
al. 2003; Vazquez, Wedel et al. 2004).  
Despite some structural variation across the subgroups of the TRPC family, there are 
several structural motifs which are conserved throughout members. The cytoplasmic N- 
and C-termini are separated by six transmembrane domains (TM1-TM6), with a re-entry 
loop between TM5 and TM6 which is thought to line the wall of the channel pore 
((Vazquez, Wedel et al. 2004) and references therein). Other shared structural motifs of 
TRPCs include ankyrin repeats and a putative caveolin binding site on the N-terminus, 
and on the C-terminus the so called TRP signature motif (EWKFAR), a proline-rich motif 
and a calmodulin/IP3 receptor binding (CIRB) site; predicted coiled-coil regions are 
present on both N- and C-termini, and in TRPC4 and 5, an extended C-terminus includes 
a PDZ binding motif (Vazquez, Wedel et al. 2004). An examination of the function of the 
TRPC cytoplasmic motifs hints at mechanisms of channel activation and signaling 
pathways. For instance, ankyrin repeats form specialized structures with the repeated 
units stacking against one another to form a protein-binding interface; this allows for 
interaction with other proteins and seems to play a role in channel trafficking to the 
plasma membrane. Coiled-coil regions are commonly associated with oligomerization and 
may contribute to formation of specific homo- and heterotetramers of TRPCs or 
association with other proteins containing coiled-coil motifs (Vazquez, Wedel et al. 2004). 
The proline-rich motif and CIRB region have also been associated to interactions with 
different signaling molecules, with variations existing throughout individual TRPC 
members. The mechanisms underlying activation and regulation of TRPC channels has 
been matter of extensive research and debate, with efforts mostly centered at elucidating 
whether they form store-operated (activated by mere depletion of internal Ca2+ stores) or 
non-store-operated channels (discussed in (Trebak, Vazquez et al. 2003; Vazquez, Wedel 
et al. 2004; Smyth, DeHaven et al. 2006). Whereas some properties of TRPC channels 
observed in heterologus expression systems correlate well with those of TRPCs expressed 
under native conditions, many others do not. It is imperative to elucidate the 
mechanism/s underlying regulation of TRPC channels in their native environment, as this 
would greatly contribute to assign definitive roles to individual TRPC members. 
Nevertheless, equally important to comprehend their role in cardiovascular physiology 
and disease is to identify cellular and molecular events which, directly or indirectly, may 
rely upon appropriate TRPC function. 
TRPC proteins are ubiquitously expressed throughout the cardiovascular system and 
hematopoietic cells and all members have been implicated not only in physiological 
cardiovascular functions but most importantly, in the pathogenesis of cardiovascular 
disease. Indeed, TRPCs have been implicated in a variety of processes known to be critical in 
cardiovascular pathology such as endothelial dysfunction, vascular relaxation, oxidative 
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stress, and angiogenesis among others. This has recently been reviewed by us (Tano, 
Smedlund et al. 2010) and others (Abramowitz and Birnbaumer 2009) and the reader is 
referred to those for further details. The following sections focus on recent findings that 
specifically point to a potential role of TRPC3 in atherorelevant processes. 
3. Participation of TRPC3 in atherorelevant molecular/cellular processes 
3.1 TRPC3 and regulated expression of VCAM-1  
Calcium signaling is an important component of the mechanism by which several 
inflammatory factors induce VCAM-1 expression. For instance, changes in intracellular Ca2+ 
associated to Ca2+ release from internal stores have been linked to the ability of Substance P 
to induce VCAM-1 subsequent to Ca2+-dependent activation of NFAT and NFκB in 
microvascular endothelium (Quinlan, Naik et al. 1999), and of ǃ2-microglobulin to induce 
VCAM-1 expression in synovial fibroblasts (Chen, O'Neill et al. 2002). In the human 
coronary endothelial cells HCAEC, Ca2+ mobilization contributes to lipoprotein A- and 
ATP-dependent VCAM-1 expression (Allen, Khan et al. 1998; Seye, Yu et al. 2003). 
Nevertheless, the specific role of Ca2+ influx in VCAM-1 expression was never directly 
examined before. In recent work we specifically explored the impact of Ca2+ influx in 
regulated expression of VCAM-1 in HCAECs (Vazquez and Putney 2006; Smedlund and 
Vazquez 2008). Our studies demonstrated that, whereas HCAECs express all members of 
the TRPC family, only TRPC3 forms, or is part of, endogenous Ca2+-permeable channels that 
contribute to ATP stimulated Ca2+ influx. Such mechanism occurs downstream ATP-
dependent activation of purinergic P2Y2 receptors and results in upregulation of VCAM-1 
total and plasma membrane associated levels with subsequent increase in monocyte 
adhesion (Smedlund and Vazquez 2008). This represented the first direct indication that 
Ca2+ influx plays a role in the signaling driving VCAM-1 expression and that TRPC3 forms 
native Ca2+-permeable channels whose activity is fundamental within the signaling 
underlying VCAM-1 expression and monocyte recruitment. Because TRPC3 is the only 
TRPC member whose high constitutive, non-regulated activity has been shown to operate 
under either heterologous or native expression conditions (Trebak, Vazquez et al. 2003) 
those findings raised the question whether TRPC3 contributes to expression of VCAM-1 
through regulated activity, constitutive activity, or both. In a follow up study using TNFǂ to 
induce VCAM-1 expression and a combination of real-time fluorescence and silencing RNA 
approaches, we conclusively showed that it is the constitutive function of TRPC3 which 
mediates most of the Ca2+ influx required for regulated expression of VCAM-1 in HCAECs 
(Smedlund and Vazquez 2008).  
In most endothelial cells VCAM-1 expression is regulated, at the transcriptional level, by 
nuclear factor kappa B (NFkB)(Zhang 2008) and we have shown that this is also the case 
in HCAECs. NFkB activation involves its release from the inhibitory protein IkBǂ and 
then the subsequent translocation of NFkB to the nucleus where it modulates 
transcriptional activity of target genes. Release of NFkB from IkBǂ is preceded by 
phosphorylation of IkBǂ by IkBǂ kinases (IKKs) followed by its ubiquitination and 
proteasomal degradation (Tergaonkar 2006). Because in most cells types examined so far 
NFkB activation depends, directly or indirectly, on Ca2+ influx, and TNFǂ-induced 
VCAM-1 requires constitutive Ca2+ influx (Smedlund, Tano et al. 2010), we examined 
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whether TRPC3, through its constitutive function, contributes to the mechanism by which 
NFkB modulates VCAM-1 expression in HCAECs. Interestingly, our studies showed that 
knockdown of TRPC3 in HCAECs drastically reduced the ability of TNFǂ to induce 
phosphorylation of IkBǂ and its upstream regulator IKKǃ (Smedlund, Tano et al. 2010), 
and this correlated with an inhibition of IkBǂ degradation. These findings indicated for 
the first time that TRPC3 constitutive function is an obligatory component in the signaling 
driving TNFǂ-dependent activation of NFkB. In addition, we showed that TRPC3-
mediated Ca2+ entry is fundamental to activate the calmodulin (CAM)/calmodulin kinase 
II (CAMKII) axis in a NADPH oxidase-dependent manner, and this signaling axis in turn 
activates NFkB (Smedlund, Tano et al. 2010). Importantly, our studies brought about a 
conceptually novel perspective on the role of TRPCs in cardiovascular disease, as they 
underscored for the first time, the potential pathological impact of upregulated expression 
of a TRPC channel endowed with high constitutive activity and how this may relate with 
pathological Ca2+-dependent signaling, independently of the canonical pathway driven by 
receptor stimulation. This is of particular interest to the field, as in those instances where 
TRPCs participate in mechanisms associated to inflammatory vascular disease (reviewed 
by us in (Tano, Smedlund et al. 2010)) their contribution relates to regulated, or receptor-
dependent channel function, rather than constitutive activity. In vivo studies are 
underway using mouse models of atherosclerosis with genetically manipulated levels of 
endothelial TRPC3 in order to determine the potential impact of TRPC3 expression and 
constitutive function in the context of the molecular and cellular events that lead to 
atherosclerotic lesion development in the intact vessel.  
3.2 TRPC3 and macrophage survival  
As stated earlier (section 2.2) the balance between apoptotic macrophages and their 
clearance by resident phagocytes at the lesion site is determinant in the progression of the 
atherosclerotic lesion. Within this context, signaling events that modulate the survival rate 
of the macrophage have a tremendous impact on such balance, provided efferocytic 
properties of resident phagocytes remain unaffected. Recent studies in our laboratory have 
implicated non-regulated, constitutive Ca2+ influx in the signaling associated with 
macrophage survival. Two major pathways are essential for the survival of macrophages in 
the atherosclerotic lesions: the phosphatidylinositol-3-kinase (PI3K)/AKT axis and the NFkB 
route. In the PI3K/AKT pathway, macrophage survival signals (v.g., insulin-like growth 
factor, prostaglandin E2) acting through either receptor tyrosine kinases or G-protein 
coupled receptors induce activation of PI3K in the plasma membrane and the subsequent 
generation of 3’-phosphorylated phosphoinositides such as phosphatidylinositol 3, 4 
bisphosphate/3,4,5 trisphosphate. These phosphoinositides allow for recruitment and 
activation of PDK-1 which then leads to full activation of AKT kinase. One of the major 
mechanisms of AKT-dependent survival takes place through AKT-mediated 
phosphorylation of the pro-apoptotic protein BAD, a member of the Bcl-2 family. Upon 
AKT-mediated phosphorylation, BAD releases the anti-apoptotic proteins Bcl-2 and Bcl-x, 
preventing mitochondrial release of cytochrome c and thus progression of the mitochondrial 
apoptotic pathway (Datta, Brunet et al. 1999). As for macrophage survival through the 
transcription factor NFκB, it is known that activation of NFkB exquisitely regulates the 
transcriptional status of several survival genes. Both of the survival pathways described 
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above are highly active in THP-1 derived macrophages (TDMs) upon exposure to the 
atherorelevant cytokine TNFǂ (Tano and Vazquez 2011). Notably, maneuvers that prevent 
constitutive Ca2+ entry through Ca2+ permeable channels drastically reduce the 
phosphorylation of IkBǂ, AKT and its downstream target BAD, with the subsequent 
increase in macrophage apoptotic rate (Tano and Vazquez 2011). In addition, when TDMs 
are pre-treated with pharmacological inhibitors of CAM and CAMKII, activation of survival 
signaling is prevented as efficiently as blockade of constitutive Ca2+ influx does. These 
findings indicated for the first time that activation of macrophage survival pathways 
depends, to a significant extent, on constitutive Ca2+ influx presumably through a 
mechanism involving the CAM/CAMKII axis (Tano and Vazquez 2011). A particularly 
interesting observation derived from those studies was that inhibition of PI3K function 
completely abrogated TNFǂ-dependent NFkB activation suggesting that the PI3K/AKT axis 
exerts a regulatory action on the NFkB pathway. Operation of such crosstalk has been 
demonstrated in cell types other than macrophages, where AKT-dependent transactivation 
of NFkB acts as an alternative AKT-dependent anti-apoptotic route independently of the 
AKT/BAD axis (Romashkova and Makarov 1999; Madrid, Wang et al. 2000; Bai, Ueno et al. 
2009). In summary, our studies suggest that in human macrophages a CAM/CAMKII axis 
links constitutive Ca2+ influx to activation of AKT, which then serves as a signaling node to 
promote survival through NFκB and/or phosphorylation of BAD. 
Macrophages from both human and mouse origin express TRPC3, and TRPC3 constitutive 
function has been shown to be operational in different cell types from these two mammalian 
species. These attributes make TRPC3 a great candidate to mediate the constitutive Ca2+ 
influx that supports the macrophage survival mechanisms described above. We indeed 
examined this possibility in recent studies that made use of bone-marrow derived 
macrophages obtained from mice globally deficient in TRPC3 (Tano, Smedlund et al. 2011). 
Macrophages derived from TRPC3 deficient bone marrow (TRPC3-/-) exhibited a significant 
reduction in constitutive cation influx compared to TRPC3+/+ cells (Tano, Smedlund et al. 
2011). Most importantly, the number of apoptotic macrophages in response to TNFǂ was 
significantly higher in TRPC3-/- cultures than in those of TRPC3+/+ macrophages, indicating 
a diminished survival in macrophages lacking TRPC3. Importantly, these observations 
correlated very well with the activation status of survival signaling: the phosphorylation of 
IkBǂ, AKT and BAD was severely reduced in TRPC3-/- macrophages (Tano, Smedlund et al. 
2011). Altogether, these findings indicated that TRPC3 has an obligatory role in macrophage 
survival and that TRPC3 is likely to mediate the constitutive Ca2+ influx required for proper 
operation of survival signaling. 
As described above, clearance of apoptotic macrophages by resident phagocytes at the 
lesion site is fundamental for appropriate inflammation resolution, and is a major factor in 
determining lesion cellularity. By means of an in vitro efferocytosis assay in which TRPC3+/+ 
and TRPC3-/- were used as either phagocytes or apoptotic cells, we observed that the 
phagocytic function of TRPC3-/- macrophages is drastically impaired when compared to that 
of TRPC3+/+ phagocytes; interestingly, apoptotic TRPC3-/- cells seem to be poor substrates 
for phagocytosis regardless of the phagocyte’s TRPC3 expression status (Tano, Smedlund et 
al. 2011). Although additional studies are required to clarify TRPC3’s role in efferocytosis, 
these findings suggest a critical requirement for TRPC3 within the signaling associated to 
phagocytic activity and/or cell-cell recognition processes that underlie efferocytosis.  
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4. TRPC3 as a prospective target in atherosclerosis: Roadmap of an exciting 
TRiP 
The rapid advance in elucidating signaling mechanisms associated to atherogenesis was 
enthusiastically perceived as an opportunity to develop anti-inflammatory strategies to 
manage the disease. However, the multifactorial nature of atherosclerosis makes such 
therapeutic strategies, often aimed at interfering on single targets, of limited efficacy and it 
is likely that multiple targeting is necessary to achieve clinically significant outcomes 
(Yonekawa and Harlan 2005; Preiss and Sattar 2007; Recio-Mayoral, Kaski et al. 2007). This 
is not surprising if we take in consideration the multifactorial nature of atherosclerosis and 
the diverse repertoire of signaling molecules and cell types that contribute to its 
pathogenesis. In that context, identifying new components of signaling events linked to 
monocyte recruitment and/or modulation of macrophage survival/apoptosis at the lesion 
site is of fundamental importance to move forward in the search for additional potential 
targets that could make those alternative therapeutic strategies a reality. Furthering our 
knowledge on the potential new roles of TRPC3, as well as other TRPC members, in 
atherogenesis can make a significant contribution to the search for new targets for the 
disease. Although ubiquitously expressed throughout tissues, TRPC3 on endothelial or 
macrophage surface could be used as a molecular target of relatively easy access for 
therapeutic and/or diagnostic purposes or may be exploited as a marker in non-invasive 
imaging, as it has been applied to other cell surface proteins (Kaufmann, Carr et al.; Saraste, 
Nekolla et al. 2009). The potential advantages of TRPC3 vs. traditional channel blockers as a 
prospective target for atherosclerosis has recently been discussed by us (Vazquez 2011). The 
exploration of TRPC3 as an atherorelevant signaling molecule is at its infancy, and several 
additional studies will be required to determine the impact of TRPC3 expression/function 
on atherorelevant events. The generation and characterization of new mouse models of 
atherosclerosis with genetically manipulated levels of TRPC3 in the atherorelevant cell or 
tissue of interest (i.e., conditional knockouts or transgenics) will be a unique contribution to 
that goal. 
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